Drug search by name

Sulfinpyrazone and Blood dyscrasias

Result of checking the interaction of drug Sulfinpyrazone and disease Blood dyscrasias for safety when used together.

Check result:

Sulfinpyrazone <> Blood dyscrasias

Relevance: 23.07.2019 Reviewer: Shkutko P.M., M.D., in

When checking interaction based on authoritative sources Drugs.com, Rxlist.com, Webmd.com, Medscape.com there are contraindications or side effects that may cause harm or increase the negative effect from drug use in presence of concomitant diseases.

Consumer:

The use of sulfinpyrazone is contraindicated in patients with a current or past history of blood dyscrasias. Anemia, leukopenia, agranulocytosis, thrombocytopenia, and aplastic anemia have been reported rarely with sulfinpyrazone use. Phenylbutazone, a structurally related agent, has been associated frequently with bone marrow suppression, as well as an increased risk of leukemia. Periodic blood counts are recommended when sulfinpyrazone or other pyrazole compounds are used.

References:

"Multum Information Services, Inc. Expert Review Panel"
"Product Information. Anturane (sulfinpyrazone)." Novartis Pharmaceuticals, East Hanover, NJ.
American Medical Association, Division of Drugs and Toxicology "Drug evaluations annual 1994." Chicago, IL: American Medical Association; (1994):

Sulfinpyrazone

Generic Name: sulfinpyrazone

Brand Name:

Synonyms: Sulfinpyrazone (Oral)

What is Sulfinpyrazone?